COVID-19 mRNA vaccine-mediated antibodies in human breast milk and their association with breast milk microbiota composition/Experiment 6/Signature 1

EditHistoryDelete

Flag for review

Your review change was submitted

Reviewed Marked as Reviewed by ChiomaBlessing on 2024-2-16

Curated date: 2023/10/24

Curator: Folakunmi

Revision editor(s): Folakunmi, Chinelsy, ChiomaBlessing

Source: supplementary table 3

Description: differential abundance of mothers at one month post second dose of BNT162b2 when compared to baseline.

Abundance in Group 1: increased abundance in Mothers at one month post second-dose

NCBI	Quality Control	Links
Acinetobacter ursingii
Campylobacter showae
Clostridiales bacterium
Dubosiella newyorkensis
Epilithonimonas hominis
Marinobacterium marisflavi
Moraxella atlantae
Neisseria elongata
Prevotella histicola
Prevotella melaninogenica
Pseudoroseomonas aestuarii
Roseomonas gilardii
Stenotrophomonas acidaminiphila
unclassified Acidovorax
unclassified Aeromicrobium
unclassified Atopobium
unclassified Brevundimonas
unclassified Corynebacteriaceae
unclassified Dermacoccaceae
unclassified Formosa
unclassified Gordonia (in: high G+C Gram-positive bacteria)
unclassified Lachnoanaerobaculum
unclassified Microvirga
unclassified Moraxella
unclassified Neisseriaceae
unclassified Novosphingobium
unclassified Paracoccaceae
unclassified Pasteurellaceae
unclassified Pediococcus
unclassified Planococcaceae
unclassified Pseudarcobacter
unclassified Rhizobiaceae
unclassified Serratia (in: enterobacteria)
unclassified Skermanella
unclassified Sphingomonas
unclassified Tepidimonas
uncultured Clostridia bacterium
un-Allorhizobium-Neorhizobium Pararhizobium-Rhizobiumun-Allorhizobium-Neorhizobium Pararhizobium-Rhizobium
unclassified chloroplastunclassified chloroplast

Revision editor(s): Folakunmi, Chinelsy, ChiomaBlessing